FHB
AVEO

First Hawaiian Bank’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

First Hawaiian Bank’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-280
Closed -$2K – 1671
2019
Q1 		$2K Buy
280
+55
+24% +$568 ﹤0.01% 1657
2018
Q4 		$4K Hold
225
– – ﹤0.01% 1657
2018
Q3 		$7K Buy
+225
New +$5.78K ﹤0.01% 1616

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

First Hawaiian Bank's AVEO Position: Q2 2019 in Review

First Hawaiian Bank sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2019, closing a stake of 280 shares — an estimated $2K sold.

First Hawaiian Bank first reported a position in AVEO in Q3 2018 and held it in 3 quarters. The position peaked at $7K in Q3 2018. 73 funds tracked by Wall St. Rank hold AVEO as of Q2 2019.

  • First Hawaiian Bank reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • First Hawaiian Bank sold 280 AVEO Pharmaceuticals, Inc. shares in Q2 2019, an estimated $2K.
  • First Hawaiian Bank first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2018 and held it in 3 quarters.
  • First Hawaiian Bank's AVEO Pharmaceuticals, Inc. position peaked at $7K in Q3 2018.
  • 73 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2019.

Based on First Hawaiian Bank's 13F filing for Q2 2019, filed 15 Jul 2019.